Top compounds associated with response to PRR20D


Feature Type Standardized
Nominal ANOVA
mRNA carboplatin:etoposide (40:17 mol/mol) CTRPv2 pan-cancer AAC -0.023 0.4
mRNA momelotinib CTRPv2 pan-cancer AAC -0.027 0.4
mRNA myricetin CTRPv2 pan-cancer AAC -0.029 0.4
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.025 0.4
mRNA Compound 7d-cis CTRPv2 pan-cancer AAC -0.028 0.4
mRNA Sunitinib CTRPv2 pan-cancer AAC -0.026 0.4
mRNA docetaxel:tanespimycin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.025 0.4
mRNA JQ-1:vorinostat (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.025 0.4
mRNA NVP-ADW742 CTRPv2 pan-cancer AAC -0.027 0.4
mRNA CHM-1 CTRPv2 pan-cancer AAC -0.024 0.4
Download CSV